Othman T, Moskoff BN, Ho G, Tenold ME, et al. Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer center. Leuk Res 2022;119:106885.
PMID: 35738024